Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase 8-associated protein 2 (CASP8AP2; also known as FLASH) is a nuclear protein involved in the regulation of apoptosis and cell cycle progression[1][3][6]. It acts as a component of the death-inducing signaling complex (DISC), interacting with Fas receptor, FADD, and caspase 8 to regulate Fas-mediated apoptosis via the extrinsic pathway[1][3]. CASP8AP2 is essential for the activation of caspase 8 in response to death receptor signaling and is required for histone gene transcription and S phase progression in the cell cycle[6]. Additionally, the protein has transcription corepressor activity, participates in SUMO polymer binding, and mediates TNF-alpha-induced activation of NF-kappa-B via TRAF2 binding, acting independently of NF-kappa-B in some contexts[2][3]. Mutations or dysregulation of CASP8AP2 are implicated in hematological cancers and developmental disorders[3]. CASP8AP2 is commonly referred to by alternative names such as FLASH, FLICE-associated huge protein, and RIP25, reflecting its discovery in different signaling and apoptotic contexts[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase 8-associated protein 2 (CASP8AP2).